TABLE 3: Current vs previous

No. of Cases (current year) and percentage change vs. previous year (persons)
Statistically significant difference in 2020 compared to 2017-2019
No statistical significant difference in 2020 compared to 2017-2019
Country average (population) Country average (country) England Scotland Northern Ireland Wales
All invasive xnmsc 345,882 (-10.3%) -10.1% 288753 (-10.2%) 30395 (-9.7%) 9273 (-8%) 17461 (-12.6%)
All xnmsc 0-24 3,582 (-5.1%) -2.3% 3043 (-5.5%) 259 (-9.2%) 108 (-5%) 172 (10.5%)
All xnmsc 25-59 78,872 (-11.7%) -12.0% 66157 (-11.7%) 6870 (-11%) 2194 (-13.6%) 3651 (-11.7%)
All xnmsc 60-79 184,754 (-10.8%) -10.3% 153320 (-10.8%) 16675 (-10.2%) 5062 (-6.2%) 9697 (-13.8%)
All xnmsc 80+ 78,674 (-7.6%) -7.9% 66233 (-7.4%) 6591 (-7.1%) 1909 (-5.8%) 3941 (-11.2%)
All registrations 539,773 (-14.2%) -15.7% 449788 (-13.8%) 46591 (-15%) 15505 (-15.1%) 27889 (-18.9%)
Haematology 30,707 (-9.5%) -9.6% 26214 (-9.5%) 2321 (-9.2%) 817 (-9.3%) 1355 (-10.6%)
Head and Neck 12,213 (-4.3%) -9.3% 10020 (-3.2%) 1228 (-5.3%) 306 (-17.5%) 659 (-11.1%)
Lower GI 44,420 (-6.6%) -9.9% 37315 (-5.2%) 3632 (-15.7%) 1176 (-8.1%) 2297 (-10.7%)
Upper GI 14,875 (-6.6%) -7.7% 12271 (-6.4%) 1434 (-5.7%) 377 (-7.8%) 793 (-11%)
HPB 20,396 (2.3%) 3.4% 17040 (2.2%) 1770 (2.7%) 556 (9.3%) 1030 (-0.7%)
Trachea, Bronchus & Lung 45,801 (-7%) -6.8% 37237 (-6.7%) 4933 (-8.9%) 1316 (-3%) 2315 (-8.3%)
Melanoma of skin 14,741 (-15.9%) -16.9% 12477 (-15.8%) 1183 (-14.5%) 324 (-18.3%) 757 (-18.8%)
Breast 48,204 (-15.2%) -13.3% 40192 (-15.6%) 4312 (-11.9%) 1363 (-9.5%) 2337 (-16.3%)
Cervix 2,840 (-12.8%) -15.3% 2371 (-11.8%) 266 (-18.2%) 73 (-12.7%) 130 (-18.4%)
Other Female Genitals 18,074 (-6%) -8.8% 15088 (-5.6%) 1583 (-5.3%) 449 (-17%) 954 (-7.3%)
Prostate 42,895 (-22.1%) -16.8% 36016 (-23.1%) 3394 (-13.7%) 1224 (-5%) 2261 (-25.3%)
Kidney 12,397 (-8.9%) -12.9% 10444 (-8.1%) 1058 (-11.5%) 296 (-21.8%) 599 (-10.3%)
Bladder 10,250 (-2.1%) -5.5% 8752 (-1.4%) 800 (-2.4%) 218 (-7.8%) 480 (-10.6%)
Brain and CNS 5,439 (-5.5%) -6.1% 4585 (-5.1%) 411 (-12.1%) 149 (-5.3%) 294 (-1.8%)
Thyroid & other endocrine glands 3,923 (-11.7%) -15.5% 3379 (-10.6%) 274 (-20.1%) 160 (1.7%) 110 (-32.9%)
CUP 7,717 (-4.4%) 0.0% 6179 (-6%) 798 (2.1%) 181 (-0.7%) 559 (4.7%)
Other invasive cancer 10,990 (-7.2%) -6.6% 9173 (-7.6%) 998 (-4%) 288 (-10.6%) 531 (-4.2%)
Breast in situ 5,853 (-30.8%) -31.7% 5099 (-30.4%) 326 (-32.6%) 194 (-23.4%) 234 (-40.3%)
Cervix in situ 19,525 (-22.2%) -33.6% 16868 (-18.4%) 1152 (-45.2%) 594 (-35.7%) 911 (-35.3%)
Other tumours 44,363 (-17.7%) -22.6% 35185 (-15.9%) 5141 (-21.8%) 2272 (-22.1%) 1765 (-30.8%)
Other non-melanoma skin cancer 1984 (-2.8%) -2.7% 1647 (-1.9%) 135 (-22.7%) 119 (14.1%) 83 (-0.4%)
Basal cell carcinoma 84241 (-26.8%) -29.2% 71364 (-26.1%) 5827 (-29.1%) 2036 (-28.3%) 5014 (-33%)
Squamous cell carcinoma 37925 (-2.6%) -3.8% 30872 (-2.7%) 3615 (1.3%) 1017 (-10.7%) 2421 (-3.2%)